Azaspiracid
Azaspiracid is a group of polyether marine toxins originally discovered in mussels from Ireland in 1995. The toxins are produced by small marine dinoflagellates such as Azadinium spinosum and Amphidoma languida. Azaspiracids are responsible for azaspiracid poisoning (AZP), a type of shellfish poisoning.
History[edit]
Azaspiracid was first identified in 1995 following a human illness outbreak in the Netherlands linked to consumption of mussels from Killary Harbour, Ireland. The toxin was named after the genus Azadinium, which was initially thought to be the source of the toxin. However, subsequent research identified Amphidoma languida as another source.
Structure and properties[edit]
Azaspiracids are a group of more than 30 related compounds, all of which share a common polycyclic structure composed of a spirocyclic ring system and a carboxylic acid group. The toxins are heat-stable and acid-stable, meaning they are not destroyed by cooking or stomach acid.
Toxicity[edit]
Azaspiracids are potent toxins that can cause severe illness in humans if ingested. Symptoms of azaspiracid poisoning (AZP) include nausea, vomiting, diarrhea, and stomach cramps. In severe cases, neurological symptoms such as memory loss and confusion may also occur. The toxins are believed to act by disrupting cellular ion channels, leading to a disruption of normal cell function.
Detection and regulation[edit]
Several methods are available for the detection of azaspiracids in shellfish, including liquid chromatography-mass spectrometry (LC-MS) and enzyme-linked immunosorbent assay (ELISA). Regulatory limits for azaspiracids in shellfish have been established by the European Union and other regulatory bodies.
See also[edit]
Azaspiracid[edit]
-
AZA Analogues
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
